Annandale Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
VCM
VPM
Annandale Capital's JNJ Position: Q1 2026 in Review
Annandale Capital reduced its Johnson & Johnson (JNJ) stake by 5.1% in Q1 2026, selling an estimated $262K and leaving 21,017 shares worth $5.14M. The position accounts for 0.72% of the portfolio, ranked #38.
Annandale Capital first reported a position in JNJ in Q4 2020 and has held it in 22 quarters since. The position peaked at $41.1M in Q3 2025. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Annandale Capital held 21,017 shares of Johnson & Johnson worth $5.14M as of Q1 2026.
- Annandale Capital sold 1,123 Johnson & Johnson shares in Q1 2026, an estimated $262K.
- Johnson & Johnson made up 0.72% of Annandale Capital's portfolio in Q1 2026, its #38 holding.
- Annandale Capital first reported a position in Johnson & Johnson in Q4 2020 and has held it in 22 quarters since.
- Annandale Capital's Johnson & Johnson position peaked at $41.1M in Q3 2025.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Annandale Capital's 13F filing for Q1 2026, filed 15 May 2026.